Latest Breaking News On - S pharmaceutical - Page 1 : comparemela.com

Astellas Pharma Inc. says it will buy U.S. pharmaceutical company Iveric Bio Inc., which focuses on ophthalmology treatments, for about $5.9 billion, as the Japanese drugmaker continues its merger and acquisition drive.

Iveric bioAstellas us holdings incAstellas pharma incIveric bio incAstellas pharmaIveric bioJapan pharmaceuticalRugmaker astellasS pharmaceutical